Go
All Publishers
24-7 Press Release Newswire
3BL Media
AccessWire
Brandpoint
Chainwire
Evertise Digital
EZ Newswire
GlobeNewswire
Get Featured
Investor Brand Network
iCrowdNewswire
KeyCrew
Prodigy Press Wire
KoreWire
Law Firm Newswire
Media OutReach
MoneyShow Newswire
NewsDirect
NewsUSA
Newsworthy.ai
Pinion Newswire
Press Advantage
PR.com
PR Newswire
PRUnderground
FirstPublisher
RestaurantNews.com
Send2Press
Syndication Cloud
Press Services
Shan News Network
StatePoint Media
WebWire
Statement by Prime Minister Carney on National Public Service Week
PR Newswire
Today at 4:27pm UTC
ROSEN, NATIONAL TRIAL ATTORNEYS, Encourages GeneDx Holdings Corp. Investors to Secure Counsel Before Important Deadline in Securities Class...
GlobeNewswire
Today at 4:23pm UTC
Positive Group LLC Shares Expert Dating Profile Tips for Herpes Singles
PressAdvantage
Today at 4:20pm UTC
Bronstein, Gewirtz & Grossman LLC Urges GeneDx Holdings Corp. Investors to Act: Class Action Filed Alleging Investor Harm
GlobeNewswire
Today at 4:00pm UTC
Bronstein, Gewirtz & Grossman LLC Urges Regencell Bioscience Holdings Ltd. Investors to Act: Class Action Filed Alleging Investor Harm
GlobeNewswire
Today at 4:00pm UTC
Bronstein, Gewirtz & Grossman LLC Urges Calix, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
GlobeNewswire
Today at 4:00pm UTC
Bronstein, Gewirtz & Grossman LLC Urges Immutep Limited Investors to Act: Class Action Filed Alleging Investor Harm
GlobeNewswire
Today at 4:00pm UTC
Bronstein, Gewirtz & Grossman LLC Urges POET Technologies Inc. Investors to Act: Class Action Filed Alleging Investor Harm
GlobeNewswire
Today at 4:00pm UTC
Bronstein, Gewirtz & Grossman LLC Urges Lucid Group, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
GlobeNewswire
Today at 4:00pm UTC
Bronstein, Gewirtz & Grossman LLC Urges SES AI Corporation Investors to Act: Class Action Filed Alleging Investor Harm
GlobeNewswire
Today at 4:00pm UTC
Bronstein, Gewirtz & Grossman LLC Urges Phreesia, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
GlobeNewswire
Today at 4:00pm UTC
Bronstein, Gewirtz & Grossman LLC Urges Verra Mobility Corporation Investors to Act: Class Action Filed Alleging Investor Harm
GlobeNewswire
Today at 4:00pm UTC
Bronstein, Gewirtz & Grossman LLC Urges Roblox Corporation Investors to Act: Class Action Filed Alleging Investor Harm
GlobeNewswire
Today at 4:00pm UTC
Bronstein, Gewirtz & Grossman LLC Urges Zillow Group, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
GlobeNewswire
Today at 4:00pm UTC
China Controls the Metals Inside Your Car, Your Phone, and Your Military. Is A Trade Deal The Only Thing Keeping That Quiet?
GlobeNewswire
Today at 3:51pm UTC
Canada Council for the Arts invests $25 million to strengthen Alberta arts communities
PR Newswire
Today at 3:30pm UTC
Modat adds Passive DNS to its Platform Magnify, Connecting Every Signal in a Single Investigation Graph
GlobeNewswire
Today at 3:00pm UTC
Muscle Growth Supplements Featuring Magnesium, Ashwagandha and Omega-3s Are Highlighted by PureHealth Research
PR Newswire
Today at 3:00pm UTC
Rosen Law Firm Encourages FLOW Cryptocurrency Investors to Inquire About Securities Class Action Investigation
PR Newswire
Today at 2:44pm UTC
Celldex Presents Long-Term Barzolvolimab Results Demonstrating Sustained Off-Treatment Improvement in Angioedema in Patients with CSU at the...
GlobeNewswire
Today at 2:21pm UTC
<
1
2
3
4
5
6
...
19
20
>
ChineseWire provides insights and opportunities in Chinese companies.
Contact us:
(310) 299-1717
twitter
facebook
linkedin
ChineseWire provides insights and opportunities in Chinese companies.
Home
About
Companies
NewsRoom
Events
Contact
Headlines
FingerMotion Inc. (FNGR) Benefiting Recurring Revenue Streams from the Top-Up Business, Expands its Product Line
Infobird Co., Ltd (NASDAQ: IFBD) Retail Product Providers Market; Extend Technological Solutions in SaaS Market
AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Leading the Way in Early Cancer Detection Space
Yimin Wu — An AI-SaaS Pioneer from the East
Contact us:
(310) 299-1717